Galderma Group N (GALD SW) stock market data APIs
CHF93.6881
-3.39(-3.6%)
as of April 25, 2025
Galderma Group N Financial Data Overview
Galderma Group AG operates as a dermatology company worldwide. The company delivers a science-based portfolio of brands and services that span the spectrum of the dermatology market, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. Its portfolio of flagship brands includes Dysport/Azzalure, Alluzience, Restylane, and Sculptra in injectable aesthetics; Cetaphil and Alastin in dermatological skincare; and Soolantra, Epiduo, Differin, Aklief, Epsolay, Twyneo, Oracea, Metvix, Benzac, and Loceryl in therapeutic dermatology. The company was founded in 1981 and is headquartered in Zug, Switzerland.
Prev. Close
93.6881
Open
90.297
High
93.6881
Low
89.8977
52 wk Range
64.75-119.6
Market Cap
22 138 M
P/E Ratio
116.5625
Shares Outstanding
237 M
Revenue
4 440 M
EPS
0.55
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Galderma Group N data using free add-ons & libraries
Get Galderma Group N Fundamental Data
Galderma Group N Fundamental data includes:
- Net Revenue: 4 440 M
- EBITDA: 891 M
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2024-07-25
- EPS/Forecast: 1.12
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Galderma Group N News
New
European Value Stocks: 3 Companies Priced Below Estimated Worth
In recent weeks, European markets have shown resilience, with the pan-European STOXX Europe 600 Index rising by nearly 4% as investor sentiment was buoyed by the European Central Bank's rate cuts and ...
European Stock Opportunities That Might Be Undervalued In April 2025
As European markets show signs of recovery, with the STOXX Europe 600 Index and major national indexes rebounding from earlier losses, investor sentiment is buoyed by the European Central Bank's recen...
Galderma Delivers Record First Quarter Net Sales of 1.129 Billion USD, Including Strong Performance From Two Launches With Blockbuster Potential, and Confirms Full-Year Guidance
Ad hoc announcement pursuant to Art. 53 LR ZUG, Switzerland, April 24, 2025--(BUSINESS WIRE)--Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, today announced its sales perfor...
Galderma launches new ALASTIN Restorative Skin Complex with Next Generation TriHex Technology®
ALASTIN by Galderma, a leader in professional grade skincare, unveils its latest innovation clinically proven to help rejuvenate skin ZUG, Switzerland, April 17, 2025--(BUSINESS WIRE)--Galderma Group...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
